Palladiem’s Medpace MEDP Stock Holding History

Palladiem’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-175	Closed	-$87.8K	–	157
2026 Q1	$87.8K	Hold	175	–	–	0.08%	76
2025 Q4	$100K	Buy	+175	New	+$99.3K	0.09%	78

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Palladiem's MEDP Position: Q2 2026 in Review

Palladiem sold out of Medpace (MEDP) in Q2 2026, closing a stake of 175 shares — an estimated $87.8K sold.

Palladiem first reported a position in MEDP in Q4 2025 and held it in 2 quarters. The position peaked at $100K in Q4 2025. 701 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Palladiem reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
Palladiem sold 175 Medpace shares in Q2 2026, an estimated $87.8K.
Palladiem first reported a position in Medpace in Q4 2025 and held it in 2 quarters.
Palladiem's Medpace position peaked at $100K in Q4 2025.
701 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Palladiem's 13F filing for Q2 2026, filed 13 Aug 2026.